Escitalopram Oxalate
Product Images NDC 68071-3265

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 68071-3265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 01)

A data table titled 'Treatment-Emergent Adverse Reactions observed with a frequency of ≥ 2% and greater than placebo for Major Depressive Disorder.' It lists adverse reactions by system category for escitalopram oxalate (N=715) compared to placebo (N=592), showing percentages for each reaction. Categories include autonomic nervous system disorders, central & peripheral nervous system disorders, gastrointestinal disorders, general, psychiatric disorders, respiratory system disorders, and urogenital, with specific symptoms and their corresponding frequencies in both treatment groups.*

FDA Label Image

2 (31e1e1b4 0738 446c 8861 Af5c49d08b54 02)

A data table titled 'TABLE 3' presenting treatment-emergent adverse reactions observed with a frequency of 2% or higher and greater than placebo for Generalized Anxiety Disorder. The table compares adverse reactions between escitalopram oxalate (N=429) and placebo (N=427), listing frequencies across several system disorders such as autonomic nervous system, central & peripheral nervous system, gastrointestinal, general, musculoskeletal, psychiatric, respiratory, and urogenital systems.*

FDA Label Image

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 03)

Chemical structure of escitalopram oxalate, showing the molecular arrangement including aromatic rings, a nitrile group (NC), a fluorine atom, and the oxalate component (C2H2O4).*

FDA Label Image

Logo (31e1e1b4 0738 446c 8861 Af5c49d08b54 04)

FDA Label Image

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 05)

FDA Label Image

68071 3265 3

Escitalopram 10mg tablets label from NuCare Pharmaceuticals, Inc., NDC 68071-3265. The label indicates a quantity of 30 tablets. Each film-coated tablet contains escitalopram oxalate USP equivalent to 10mg escitalopram. Tablets are described as round, white to off-white, biconvex, with debossed markings. The label includes storage instructions and warnings, along with barcodes and lot/serial information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.